Geninus (지니너스) uses big data analysis for genomics, with solutions in liquid biopsy, cancer genomics, risk prediction of chronic diseases, personalized weight management and more. The company has built a database of cancer gene mutation frequencies, by utilizing over 150,000 public genome databases and over 15,000 clinical specimen databases obtained in partnership with Samsung Medical Center. Core technologies by Geninus include bidirectional sequencing, CNV mutation detection, fusion mutation detection, SNV/indel mutation detection, and MSI/TMB mutation detection.